Paper3919944
Anthracycline resistance in P388 murine leukemia and its circumvention by calcium antagonists.
Kessel D and 1 other. Cancer Res, 1985. Cited by 178 papers, by iCite.
Cite this record
ConductScience Library. Anthracycline resistance in P388 murine leukemia and its circumvention by calcium antagonists. Papers, record 3919944. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3919944
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Anthracycline resistance in P388 murine leukemia and its circumvention by calcium antagonists.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibiotics, Antineoplastic | Major topic |
| Calcium Channel Blockers | Major topic |
| Leukemia P388 | Major topic |
| Leukemia, Experimental | Major topic |
| Animals | |
| Calcium | |
| Cell Line | |
| Daunorubicin | |
| Drug Resistance | |
| Egtazic Acid | |
| Mice | |
| Naphthacenes | |
| RNA, Messenger |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| CA 31331 | NCI NIH HHS | United States | R01CA031331 | PubMed and NIH |
Source NIH RePORTER
Cited by29
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 178 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 8807402 | Cellular drug efflux and reversal therapy of cancer. | J Bioenerg Biomembr | 1996 | https://conductscience.org/library/papers/8807402 | PubMed |
| 8100823 | Pharmacological and molecular characterization of intrinsic and acquired doxorubicin resistance in murine tumor cell lines. | J Cancer Res Clin Oncol | 1993 | https://conductscience.org/library/papers/8100823 | PubMed |
| 8004759 | Quantification of topoisomerase-DNA complexes in leukemia cells from patients undergoing therapy with a topoisomerase-directed agent. | Cancer Chemother Pharmacol | 1994 | https://conductscience.org/library/papers/8004759 | PubMed |
| 7841045 | Selective photodynamic inactivation of a multidrug transporter by a cationic photosensitising agent. | Br J Cancer | 1995 | https://conductscience.org/library/papers/7841045 | PubMed |
| 7841041 | Combination therapy with cisplatin and nifedipine induces apoptosis in cisplatin-sensitive and cisplatin-resistant human glioblastoma cells. | Br J Cancer | 1995 | https://conductscience.org/library/papers/7841041 | PubMed |
| 7765325 | Pharmacologic circumvention of multidrug resistance. | Cytotechnology | 1993 | https://conductscience.org/library/papers/7765325 | PubMed |
| 3947509 | Resistance of human glioma to adriamycin in vitro: the role of membrane transport and its circumvention with verapamil. | Br J Cancer | 1986 | https://conductscience.org/library/papers/3947509 | PubMed |
| 3815723 | Effect of verapamil on daunorubicin accumulation in Ehrlich ascites tumor cells. | Cancer Chemother Pharmacol | 1987 | https://conductscience.org/library/papers/3815723 | PubMed |
| 3741759 | Cyclosporin A corrects daunorubicin resistance in Ehrlich ascites carcinoma. | Br J Cancer | 1986 | https://conductscience.org/library/papers/3741759 | PubMed |
| 3730255 | Characterization of a doxorubicin-resistant murine melanoma line: studies on cross-resistance and its circumvention. | Br J Cancer | 1986 | https://conductscience.org/library/papers/3730255 | PubMed |
| 3707847 | Role of the calmodulin inhibitor trifluoperazine on the induction and expression of cell cycle traverse perturbations and cytotoxicity of daunorubicin and doxorubicin (adriamycin) in doxorubicin-resistant P388 mouse leukaemia cells. | Br J Cancer | 1986 | https://conductscience.org/library/papers/3707847 | PubMed |
| 3600053 | Sensitivity and resistance to chemotherapy in acute leukemia: correlation with in vitro drug uptake and lack of potentiation by verapamil. | Med Oncol Tumor Pharmacother | 1987 | https://conductscience.org/library/papers/3600053 | PubMed |
| 3457021 | Cyclosporin A reverses vincristine and daunorubicin resistance in acute lymphatic leukemia in vitro. | J Clin Invest | 1986 | https://conductscience.org/library/papers/3457021 | PubMed |
| 3435701 | Increased plasma membrane traffic in daunorubicin resistant P388 leukaemic cells. Effect of daunorubicin and verapamil. | Br J Cancer | 1987 | https://conductscience.org/library/papers/3435701 | PubMed |
| 3284909 | Genetics of multidrug resistance. | J Clin Invest | 1988 | https://conductscience.org/library/papers/3284909 | PubMed |
| 3207599 | Cross resistance pattern towards anticancer drugs of a human carcinoma multidrug-resistant cell line. | Br J Cancer | 1988 | https://conductscience.org/library/papers/3207599 | PubMed |
| 3179186 | Modulation in vitro and in vivo of cytotoxicity but not cellular levels of doxorubicin by the calmodulin inhibitor trifluoperazine is dependent on the level of resistance. | Br J Cancer | 1988 | https://conductscience.org/library/papers/3179186 | PubMed |
| 3165724 | Correction of altered plasma membrane potentials. A possible mechanism of cyclosporin A and verapamil reversal of pleiotropic drug resistance in neoplasia. | Cancer Chemother Pharmacol | 1988 | https://conductscience.org/library/papers/3165724 | PubMed |
| 3056253 | Endogenous active efflux of norfloxacin in susceptible Escherichia coli. | Antimicrob Agents Chemother | 1988 | https://conductscience.org/library/papers/3056253 | PubMed |
| 3028774 | A 22-kd protein (sorcin/V19) encoded by an amplified gene in multidrug-resistant cells, is homologous to the calcium-binding light chain of calpain. | EMBO J | 1986 | https://conductscience.org/library/papers/3028774 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3919944
GET https://conductscience.org/api/papers/v1/3919944/cited_by?page=2